SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-026818
Filing Date
2015-05-01
Accepted
2015-05-01 09:58:46
Documents
3
Period of Report
2015-04-28
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v408958_8k.htm 8-K 25530
2 EXHIBIT 99.1 v408958_ex99-1.htm EX-99.1 17965
3 GRAPHIC image_002.jpg GRAPHIC 4352
  Complete submission text file 0001144204-15-026818.txt   51055
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 804-205-5069
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23930 | Film No.: 15822286
SIC: 2836 Biological Products, (No Diagnostic Substances)